Stockscreener 앱 받기
134.57
0.30%
0.40
시간 외 거래:
134.57
전일 마감가:
$134.17
열려 있는:
$134.09
하루 거래량:
5.89M
Relative Volume:
0.94
시가총액:
$234.21B
수익:
$43.11B
순이익/손실:
$13.94B
주가수익비율:
16.86
EPS:
7.98
순현금흐름:
$6.78B
1주 성능:
+1.45%
1개월 성능:
+3.30%
6개월 성능:
+6.55%
1년 성능:
+17.14%
1일 변동 폭
$132.09
$134.78
1주일 범위
$130.96
$134.96
52주 변동 폭
$110.86
$140.84
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
134.57 | 233.52B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.23 | 145.95B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.84 | 144.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.59 | 121.32B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.55 | 44.15B | 5.69B | 1.41B | 577.90M | 6.95 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Is it the Right Time to Retain Abbott Stock in Your Portfolio? - sharewise.com
Abbott updates instructions for TactiFlex ablation catheter following instances of tip damage - MassDevice
Neuromodulation Market is expected to generate a revenue of USD 9.32 Billion by 2032, Globally, at 9.27% CAGR: Verified Market Research® - GlobeNewswire Inc.
Stokes Capital Advisors LLC Reduces Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Procyon Advisors LLC - MarketBeat
Abbott Laboratories $ABT Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Pallas Capital Advisors LLC Acquires 2,007 Shares of Abbott Laboratories $ABT - MarketBeat
StrongBox Wealth LLC Acquires 3,011 Shares of Abbott Laboratories $ABT - MarketBeat
Divergent Planning LLC Purchases Shares of 29,653 Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Dynamic Advisor Solutions LLC - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Inspirion Wealth Advisors LLC - MarketBeat
Balefire LLC Increases Holdings in Abbott Laboratories $ABT - MarketBeat
Gradient Investments LLC Acquires 7,680 Shares of Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
New England Research & Management Inc. Has $1.41 Million Position in Abbott Laboratories $ABT - MarketBeat
Fiduciary Alliance LLC Raises Stock Position in Abbott Laboratories $ABT - MarketBeat
St. Louis Financial Planners Asset Management LLC Purchases Shares of 18,301 Abbott Laboratories $ABT - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat
Little House Capital LLC Has $1.03 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Rep. Julie Johnson Sells Off Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott (ABT) Gains As Market Dips: What You Should Know - sharewise.com
Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest? - Nasdaq
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Canandaigua National Bank & Trust Co. Lowers Holdings in Abbott Laboratories $ABT - MarketBeat
Goldstone Financial Group LLC Sells 4,017 Shares of Abbott Laboratories $ABT - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Raises Stock Position in Abbott Laboratories $ABT - MarketBeat
Abner Herrman & Brock LLC Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Red Spruce Capital LLC Has $3.86 Million Position in Abbott Laboratories $ABT - MarketBeat
Parallel Advisors LLC Boosts Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by TruWealth Advisors LLC - MarketBeat
Jones Financial Companies Lllp Has $45.84 Million Stake in Abbott Laboratories $ABT - MarketBeat
Integrity Alliance LLC. Boosts Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Holdings Lifted by Intech Investment Management LLC - MarketBeat
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
Empowered Funds LLC Has $6.73 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Medtech Wins Two 2025 R&D 100 Awards - R&D World
US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - GlobeNewswire
There's No Escaping Abbott Laboratories' (NYSE:ABT) Muted Earnings - simplywall.st
Doliver Advisors LP Has $2.09 Million Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Jacobs & Co. CA - MarketBeat
Park National Corp OH Sells 9,998 Shares of Abbott Laboratories $ABT - MarketBeat
Barrett's Esophagus Strategic Business Report 2025-2030 Featuring 34 Companies - GlobeNewswire Inc.
Pensionfund Sabic Sells 4,000 Shares of Abbott Laboratories $ABT - MarketBeat
First Hawaiian Bank Reduces Position in Abbott Laboratories $ABT - MarketBeat
Schmidt P J Investment Management Inc. Decreases Position in Abbott Laboratories $ABT - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $1.39 Billion Holdings in Abbott Laboratories $ABT - MarketBeat
AG2R LA Mondiale Gestion D Actifs Buys New Shares in Abbott Laboratories $ABT - MarketBeat
Swedbank AB Sells 77,261 Shares of Abbott Laboratories $ABT - MarketBeat
Modern Wealth Management LLC Raises Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Fred Alger Management LLC Acquires 108,690 Shares of Abbott Laboratories $ABT - MarketBeat
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.25%
자본화:
|
볼륨(24시간):